Chartwell Investment Partners LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,415 shares of the healthcare conglomerate's stock after selling 9,867 shares during the quarter. UnitedHealth Group comprises 1.0% of Chartwell Investment Partners LLC's investment portfolio, making the stock its 9th biggest holding. Chartwell Investment Partners LLC's holdings in UnitedHealth Group were worth $29,476,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock worth $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate's stock worth $30,000 after acquiring an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after purchasing an additional 32 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
A number of analysts recently commented on the company. Stephens decreased their price target on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Thursday, October 17th. Robert W. Baird lifted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an "outperform" rating in a report on Wednesday, July 17th. Jefferies Financial Group raised UnitedHealth Group from a "hold" rating to a "buy" rating and raised their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, Barclays decreased their price objective on UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $615.53.
Get Our Latest Analysis on UNH
Shares of UNH opened at $615.81 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The firm has a market cap of $566.72 billion, a price-to-earnings ratio of 40.12, a PEG ratio of 1.81 and a beta of 0.58. The firm has a 50 day moving average price of $581.93 and a 200-day moving average price of $545.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $619.80.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. During the same period in the prior year, the business posted $6.56 EPS. UnitedHealth Group's quarterly revenue was up 9.2% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.72%.
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.